A clinical trial has begun which will use stem cell transplants to grow a new immune system for people with untreatable Crohn’s disease – a painful and chronic intestinal disease which affects at least 115,000 people in the UK. The study, led by Queen Mary University of London and Barts Health NHS trust, is funded … Read more
REACT clinical trial supports new approach of accelerated treatment for Crohn’s disease – The final results from an international clinical trial involving nearly 2,000 patients with Crohn’s disease support the use of a new management strategy referred to as accelerated step-care as a best practice for the care of active Crohn’s disease.
Studies show vedolizumab is an effective treatment for Crohn’s disease and ulcerative colitis – Investigational antibody vedolizumab is an effective treatment for those suffering from ulcerative colitis (UC) and Crohn’s disease (CD) when other treatments have failed, revealed in an international clinical trial.
Banana plantain fibers could treat Crohn’s disease – Crohn’s is a condition that affects one in 800 people in the UK and causes chronic intestinal inflammation, leading to pain, bleeding and diarrhoea. Researchers are working with biotechnology company, Provexis, to test a new plantain based food product that could treat patients with the disease.
Cimzia(R) (certolizumab pegol) Now Available for Self-Administration in Adult Patients With Moderate to Severe Crohn’s Disease – Cimzia (certolizumab pegol), the only PEGylated anti-TNF (Tumor Necrosis Factor) for reducing signs and symptoms of Crohn’s disease is now available for self-administration in a prefilled syringe.
This international research study, published in The Lancet, has thrown into question the current method of treating Crohn’s disease ? opening the door to a safer and more effective treatment option for sufferers of the chronic disease. – A new study established the new alternative strategy, called “top-down” therapy, to treat the patients with Crohn’s disease by employing early use of immune-suppressing drugs combined with an antibody without using steroids.
Mycobacterium paratuberculosis found in cows milk may cause Crohn’s disease in humans, revealed by researchers at the University of Liverpool, UK.
– Researchers at the University of Liverpool have found how a bacterium, known to cause illness in cattle, may cause Crohn’s disease in humans. Crohn’s is a condition that affects one in 800 people in the UK and causes chronic intestinal inflammation, leading to pain, bleeding and diarrhoea.